The global oxiracetam injection market is anticipated to grow at a CAGR of 4.0% during the forecast period (2022- 2028). Oxiracetam is a nootropic drug of the racetam family and a very mild stimulant. It is one of the brain-booster and most popular nootropics. It is used to treat cognitive deficits of cerebrovascular origins and has mild stimulant capability. The nootropic drug is well-known for its ability to boost mental energy, cognition, and memory. It is available in the form of injections and capsules. The injection form is widely used for stroke patients whose memories were affected, while the oral form is used for patients with Alzheimer’s disease. The rise in demand for brain boosters and high consumer awareness about brain health and also the rise in Alzheimer’s disease, dementia, and other neurological problems are the factors that boost the growth of the market. Factors such as the increasing aging population, alcohol and drug abuse, and other trauma resulting in short memory are propelling the demand for the oxiracetam injection. Side effects such as elevated blood pressure due to hypertension restrain the growth of the market.
Some major companies in the market include Haerbin Medisan Pharmaceutical Co Ltd, CSPC Pharmaceutical Group Ltd, and Guangdong Shixin Pharmaceutical Co. Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships, new product launches, and collaborations, to stay competitive in the market.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Oxiracetam Injection Market at: https://orionmarketreports.com/request-sample/?id=96985&submit=Request+Sample%0D%0A
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Distribution Channel
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– HaerbinMedisan Pharmaceutical Co Ltd., CSPC Pharmaceutical Group Ltd., and Guangdong Shixin Pharmaceutical Co. Ltd., among others.
A full report Oxiracetam Injection Market of is available at: https://orionmarketreports.com/oxiracetam-injection-market/96985/
Global Oxiracetam Injection Market Report by Segment
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Others
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
